✦ LIBER ✦

Pilot phase II trial of radiation “sandwiched” between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)

✍ Scribed by Abbie L. Fields; Mark H. Einstein; Akiva P. Novetsky; Juliana Gebb; Gary L. Goldberg

Book ID: 113961375
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 223 KB
Volume: 108
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2007.09.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective phase II trial of adjuvant p

Prospective phase II trial of adjuvant pelvic radiation “sandwiched” between paclitaxel and carboplatin combination chemotherapy in women with uterine papillary serous carcinoma

✍ M. Einstein; M. Frimer; R. Phaeton; L. Reimers; K. Mehta; S. Mutyala; D. Kuo; G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II trial of adjuvant pelvic radiat

Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma

✍ Mark H. Einstein; Marina Frimer; Dennis Y.-S. Kuo; Laura L. Reimers; Keyur Mehta 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Platinum-free combination chemotherapy i

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate

✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab